ArticleOPEN ACCESS

Tocilizumab and multiple sclerosis: A causal relationship? Clinical Commentary on the case report entitled - MS arising during Tocilizumab therapy for rheumatoid arthritis

Multiple Sclerosis
DOI: 10.1177/1352458515623863
6Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This clinical commentary discusses on the potential relationship between multiple sclerosis (MS) and tocilizumab in a patient with rheumatoid arthritis who developed MS while on treatment with this anti-interleukin-6 agent.

Author supplied keywords

Cite

CITATION STYLE

APA

Comabella, M. (2016, February 1). Tocilizumab and multiple sclerosis: A causal relationship? Clinical Commentary on the case report entitled - MS arising during Tocilizumab therapy for rheumatoid arthritis. Multiple Sclerosis. SAGE Publications Ltd. https://doi.org/10.1177/1352458515623863

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free